Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT01124708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Randomized, Placebo-controlled, Multicenter, Fixed Dose Titration Study to Assess Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Study identification
- NCT ID
- NCT01124708
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Targacept Inc.
- Industry
- Enrollment
- 134 participants
Conditions and interventions
Conditions
Interventions
- TC-5619-238 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2010
- Primary completion
- Jan 31, 2011
- Completion
- Jan 31, 2011
- Last update posted
- Sep 12, 2013
2010 – 2011
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Clinical Research Center, LLC | Bradenton | Florida | 34208 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32216 | — |
| Fidelity Clinical Research, Inc | Lauderhill | Florida | 33319 | — |
| Florida Clinical Research Center, LLC | Maitland | Florida | 32751 | — |
| Scientifc Clinical Research, Inc. | North Miami | Florida | 33161 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32806 | — |
| Atlanta Center For Clinical Research | Atlanta | Georgia | 30308 | — |
| CRI Worldwide, LLC (Lourdes Division) | Willingboro | New Jersey | 08046 | — |
| Neuro-Behavioral Clinical Research, Inc. | Canton | Ohio | 44718 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| Oregon Center For Clinical Investigations, Inc. (OBBI, Inc.) | Portland | Oregon | 97210 | — |
| CRI Worldwide, LLC (Kirkbride Division) | Philadelphia | Pennsylvania | 19139 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| FutureSearch Clinical Trials, LP | Austin | Texas | 78756 | — |
| Claghorn-Lessem Research Clinic | Houston | Texas | 77008 | — |
| Fletch Allen Health Care, Dept. of Psychiatry, Univ. of Vermont | Burlington | Vermont | 05401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01124708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01124708 live on ClinicalTrials.gov.